Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH

Watchlist Manager
Fisher & Paykel Healthcare Corporation Ltd Logo
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
Watchlist
Price: 38.55 NZD 4.3% Market Closed
Market Cap: 22.6B NZD
Have any thoughts about
Fisher & Paykel Healthcare Corporation Ltd?
Write Note

Gross Margin
Fisher & Paykel Healthcare Corporation Ltd

59.9%
Current
61%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
59.9%
=
Gross Profit
1B
/
Revenue
1.7B

Gross Margin Across Competitors

Country NZ
Market Cap 22.5B NZD
Gross Margin
60%
Country US
Market Cap 204.9B USD
Gross Margin
56%
Country US
Market Cap 195.2B USD
Gross Margin
67%
Country US
Market Cap 146.7B USD
Gross Margin
64%
Country US
Market Cap 132.6B USD
Gross Margin
69%
Country IE
Market Cap 110.6B USD
Gross Margin
66%
Country US
Market Cap 64.7B USD
Gross Margin
45%
Country DE
Market Cap 55.6B EUR
Gross Margin
38%
Country CN
Market Cap 319.2B CNY
Gross Margin
65%
Country US
Market Cap 41.6B USD
Gross Margin
79%
Country US
Market Cap 37.7B USD
Gross Margin
41%
No Stocks Found

Fisher & Paykel Healthcare Corporation Ltd
Glance View

Market Cap
22.5B NZD
Industry
Health Care

Fisher & Paykel Healthcare Corporation Ltd., a leading provider of innovative medical devices and respiratory products, has carved a prominent niche in the global healthcare market. Founded in New Zealand in 1934, the company has evolved from a humble appliance manufacturer into a key player in respiratory care and sleep medicine. With a mission centered on improving patient outcomes, Fisher & Paykel leverages its strong research and development capabilities to create state-of-the-art products, such as its award-winning humidifiers and nasal mask systems, designed to support patients with respiratory issues and obstructive sleep apnea. The company boasts a diverse international presence, with a robust distribution network that allows it to serve healthcare professionals and patients in over 120 countries. For investors, Fisher & Paykel stands out not only for its continual focus on innovation but also for its stable financial performance. Throughout its history, the company has demonstrated resilience and adaptability, adeptly navigating market fluctuations and healthcare trends. With a strong balance sheet, a consistent track record of revenue growth, and a commitment to shareholder returns, Fisher & Paykel is well-positioned for future expansion, particularly as global healthcare demands rise. As the aging population and the increasing prevalence of chronic respiratory conditions drive market growth, investors may find Fisher & Paykel Healthcare a compelling opportunity, with its blend of innovative solutions and solid financial foundations paving the way for sustained success.

FPH Intrinsic Value
23.16 NZD
Overvaluation 40%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
59.9%
=
Gross Profit
1B
/
Revenue
1.7B
What is the Gross Margin of Fisher & Paykel Healthcare Corporation Ltd?

Based on Fisher & Paykel Healthcare Corporation Ltd's most recent financial statements, the company has Gross Margin of 59.9%.